Cash, cash equivalents, and marketable securities totaled $420.8 million as of December 31, 2024. Septerna (SEPN) expects its current cash position to support its planned operations into early 2028.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SEPN:
- Septerna, Inc. Shifts Focus to Next-Gen PTH1R Agonist
- Hold Rating for Septerna, Inc. Amid Lead Program Discontinuation and Pipeline Uncertainty
- Wells Fargo downgrades Septerna after lead program SEP-786 discontinued
- Septerna downgraded to Equal Weight from Overweight at Wells Fargo
- Septerna discontinues SEP-786 Phase 1 clinical trial in hypoparathyroidism
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue